Growth Metrics

InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for InMed Pharmaceuticals (INM) over the last 4 years, with Q3 2025 value amounting to 0.33.

  • InMed Pharmaceuticals' Asset Utilization Ratio fell 2550.99% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 2550.99%. This contributed to the annual value of 0.36 for FY2025, which is 172.03% up from last year.
  • According to the latest figures from Q3 2025, InMed Pharmaceuticals' Asset Utilization Ratio is 0.33, which was down 2550.99% from 0.4 recorded in Q2 2025.
  • InMed Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.55 for Q1 2025, and its period low was 0.08 during Q2 2022.
  • In the last 4 years, InMed Pharmaceuticals' Asset Utilization Ratio had a median value of 0.37 in 2023 and averaged 0.32.
  • Per our database at Business Quant, InMed Pharmaceuticals' Asset Utilization Ratio surged by 30898.32% in 2023 and then crashed by 2550.99% in 2025.
  • InMed Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.1 in 2022, then soared by 308.98% to 0.42 in 2023, then grew by 21.52% to 0.51 in 2024, then plummeted by 34.92% to 0.33 in 2025.
  • Its last three reported values are 0.33 in Q3 2025, 0.4 for Q2 2025, and 0.55 during Q1 2025.